Yuzhi Li

[IL-17A/lL-17RA reduces cisplatin sensitivity of ovarian cancer SKOV3 cells by regulating autophagy].

Liangliang Wang, Lihua Wang, Beibei Wang, 2020, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.

Hongli Liu, Ling Ma, Jian Liu, 2017, Journal of cancer research and therapeutics.

Erb-B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53-responsive microRNA-3184-5p in cervical cancer cells

N. Wu, Hongli Liu, Hongtao Wang, 2020, Oncology reports.

430 A phase 1b/II clinical study of AK112, a PD-1/VEGF bispecific antibody, in combination with olaparib in BRCA germline wild-type platinum sensitive recurrent ovarian cancer

R. An, Xiaoping Jin, Lingying Wu, 2021, Journal for ImmunoTherapy of Cancer.

Efficacy and mechanism of osimertinib combined with bevacizumab in the treatment of postoperative EGFR positive stage II-IIIA lung adenocarcinoma.

Yi Wang, Junfeng Gao, Hao Wang, 2022, American journal of translational research.

Folate receptor alpha promotes endometrial carcinoma cell proliferation and inhibits apoptosis by regulating the ERK signaling pathway

Y. Zhang, Jing Liu, Jing Zhang, 2019 .

Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)

N. Xu, G. Lou, Qi Zhou, 2022, Gynecologic Oncology.

Signet ring cell carcinoma of the bladder.

Delin Yang, Chengxing Xia, Bin Yang, 2023, Asian journal of surgery.